<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02459717</url>
  </required_header>
  <id_info>
    <org_study_id>66/INT/2015</org_study_id>
    <nct_id>NCT02459717</nct_id>
  </id_info>
  <brief_title>Pre-biotics and Probiotics for Constipation in Parkinson's Disease</brief_title>
  <official_title>Double Blind, Placebo-controlled Trial of a Fermented Milk Containing Multiple Probiotics Strains and Prebiotic Fiber for Constipation Associated With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emanuele Cereda</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IRCCS Istituto Neurologico Mondino, Pavia, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituti Clinici di Perfezionamento di Milano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Constipation is the most frequent (prevalence, about 60%) dysautonomic non motor symptom
      affecting Parkinson's disease (PD) patients. Unfortunately, limited treatment options have
      been investigated and are now available for the management of constipation in PD. Preliminary
      data have suggested that probiotics could be help improving bowel habits but high-quality
      randomized trials are required in this area. Therefore, the investigators designed a
      randomized trial to evaluate whether the use of a fermented milk containing multiple
      probiotics strains and prebiotic fiber have a beneficial effect on constipation in PD
      compared to placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete bowel movements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in the mean number of complete spontaneous bowel movements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of bowel movements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in the mean number of spontaneous bowel movements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool consistency</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in mean stool consistency (scored with the use of the 7-point Bristol Stool Form Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laxative use</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in the mean use of laxative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment satisfaction</measure>
    <time_frame>4 weeks</time_frame>
    <description>Satisfaction with the trial medication's ability to relieve constipation symptoms as assessed by a self-rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment continuation</measure>
    <time_frame>4 weeks</time_frame>
    <description>Likelihood that patients would continue taking the trial treatment as assessed by a self-rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in one or more complete bowel movements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentage of patients reporting an increase in one or more complete bowel movements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of three or more complete bowel movements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Percentage of patients reporting three or more complete bowel movements</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Probiotics and prebiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>fermented milk (125 grams), containing multiple probiotics strains and prebiotic fiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>pasteurized fermented milk (125 grams) without prebiotics</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probiotics and prebiotic</intervention_name>
    <description>Patients will receive daily (at breakfast) a fermented milk (125 grams), containing multiple probiotics strains and prebiotic fiber</description>
    <arm_group_label>Probiotics and prebiotic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients will receive daily (at breakfast) a placebo (pasteurized fermented milk without prebiotics)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of constipation according to Roma III criteria

          -  complete bowel movements per week &lt;3

          -  total bowel movements per week &lt;6

          -  written informed consent

        Exclusion Criteria:

          -  report of loose (mushy) or watery stool in the absence of laxative use

          -  ongoing artificial nutrition

          -  lactose intolerance

          -  chronic inflammatory bowel disease

          -  previous abdominal surgery

          -  use of anti-cholinergics

          -  use of antibiotics in the 6 weeks before baseline visit

          -  Radio- chemotherapy

          -  Cognitive decline (Mini Mental State Examination &lt;27)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio Pacchetti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Istituto Neurologico Mondino</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Istituto Neurologico Mondino</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Matteo</investigator_affiliation>
    <investigator_full_name>Emanuele Cereda</investigator_full_name>
    <investigator_title>Co-project Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

